Membrane rigidity

Membrane rigidity is a biophysical property that characterizes the mechanical stiffness and molecular packing density of the cellular lipid bilayer. This property is primarily determined by the ratio of various lipids, such as cholesterol, sphingolipids, and the saturation level of fatty acid chains within the plasma membrane. In biological systems, membrane rigidity plays a crucial role in regulating signal transduction, cell migration, and the passive diffusion of molecules. Pathologically, increased membrane rigidity is often observed in multidrug-resistant cancer cells, where it acts as a barrier to chemotherapeutic entry, while decreased rigidity is frequently associated with increased metastatic potential and invasiveness. Pharmacological agents can modulate membrane rigidity either indirectly by inhibiting lipid synthesis pathways (e.g., statins reducing cholesterol levels) or directly by intercalating into the bilayer to disrupt or stabilize lipid packing (e.g., azelates or hydrophobic peptides). Targeting this biophysical state, often referred to as membrane lipid therapy, represents a non-canonical approach to treating cancer, infectious diseases, and inflammatory disorders.

Other names

Membrane stiffnessMembrane orderMembrane fluidity (inverse)Bending rigidityLipid bilayer stiffnessPlasma membrane rigidity

Modulation of lipid bilayer composition through the depletion of membrane sterols or the alteration of fatty acid saturation levels, which changes the molecular order and mechanical resistance of the plasma membrane to deformation.